TYT Wight loss Lyophilized powder Semaglutide Petide CAS 910463-68-2 weight loss peptides
161 Inquiries
910463-68-2
Pharmaceutical Grade
99.9%
TIANJIN
TYT
5mg 10mg 15mg 30mg per vial; 10vials/box
Yes
2024-07-12
peptide
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial Reference
Semaglutide (CAS: 910463‑68‑2) is a synthetic lipid‑modified peptide analogue, consisting of a 31‑amino‑acid backbone with a covalently attached C18 fatty di‑acid side‑chain via a hydrophilic spacer. It shares 94% amino‑acid sequence homology with native human GLP‑1 peptide. The substance appears as white to almost white hygroscopic powder, with molecular formula C₁₈₇H₂₉₁N₄₅O₅₉ and molecular weight of 4113.58 g/mol. Structural modifications grant it resistance against DPP‑4 enzymatic degradation and enable reversible binding to serum albumin, contributing to its extended in‑vivo half‑life property.
Basic Info-
Product Name:
Semaglutide
Other Name:Sermaglutide;Semaglutide impurity;Sermaglutide USP/EP/BP;semaglutide;Sermaglutide CAS 910463 68 2;Semaglutide (H-7894.0001);semgalutide;Semaglutide
CAS No.:910463-68-2
Molecular Formula:C187H291N45O59
InChIKeys:DLSWIYLPEUIQAV-CCUURXOWSA-N
Molecular Weight:4113.57754
Exact Mass:4113.122087 g/mol
EC Number:203-405-2
Color/Form:White to off-white
Categories:
Characteristics-
PSA:
1650 Ų
XLogP3:5.44520
Critical Temperature & Pressure:Store at -20°C
Research-
Class:
GLP-1R agonist
Status:FDA-approved (Ozempic / Wegovy / Rybelsus)
Mechanism:Long-acting, selective glucagon-like peptide-1 (GLP-1) receptor agonist with 94% sequence homology to human GLP-1. Engineered for extended half-life (~1 week) via albumin binding (fatty acid acylation at Lys26) and resistance to DPP-4 degradation (Aib substitution at position 8). Promotes insulin secretion, inhibits glucagon release, delays gastric emptying, and reduces appetite via central nervous system GLP-1R activation.
Activity note:Potent, selective GLP-1R agonist. Reported binding affinity Ki = 0.38 ± 0.06 nM. Semaglutide is a human GLP-1 analog with structural modifications for albumin binding (C18 fatty diacid at Lys26) and enzymatic stability (Aib8 substitution).
Source:Lau J, et al. J Med Chem. 2015;58(18):7370-7380. Wilding JPH, et al. N Engl J Med. 2021;384(11):989-1002.DOI
Clinical Development:FDA:Ozempic, Wegovy, Rybelsus (approved 2017-12-05)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Literature:
NEJM: Wilding et al. (2021) — STEP-1; NEJM: Marso et al. (2016) — SUSTAIN-6; J Med Chem: Lau et al. (2015) — Discovery of Semaglutide; FDA: Ozempic (NDA 209637)
Disclaimer:Semaglutide is approved as a prescription medicine (Ozempic, Wegovy, Rybelsus) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
Hazard IdentificationClassification of the substance or mixture
Reproductive toxicity, Category 2
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Warning
Hazard statement(s) H361 Suspected of damaging fertility or the unborn child
Precautionary statement(s) Prevention P203 Obtain, read and follow all safety instructions before use.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
Response P318 IF exposed or concerned, get medical advice.
Storage P405 Store locked up.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
peptide
-
Location:
No.14, 5/F, Building 2, No.118, Weijia118, Jinniu District, Chengdu, Sichuan, China
-
Payment Terms:
TT against copy of documents,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
15 days
-
Total Annual Revenue:
Less than $1 million
-
Total Employees:
51-100
-
Year of Establishment:
2024
Company Certificates-
Product Sales Authorization
-
-
Inquiry History161 Inquiries
Country Product Purchase Quantity Date Posted 
United States
Sermaglutide 99% 910463-68-2
2 KG Oct 21, 2023
United States
semaglutide
30 MG Mar 25, 2026 
Hongkong, China
Semaglutide910463-68-2Tirzepatide2023788-19-2Retatrutide2381089-83-2
1 MT Aug 18, 2025 
New Zealand
Semaglutide
1 G Mar 18, 2026 
Vietnam
semaglutide powder
10 G Sep 26, 2024 
India
Semaglutide
1.00 KG Oct 8, 2024
United States
Semaglutide
10 MT Sep 25, 2026 
United Kingdom
Semaglutide
10 G Sep 17, 2026 
Germany
Semaglutide
200 MG Jul 24, 2026
Germany
Semaglutide
500 MG Jul 24, 2026 
United Arab Emirates
Semaglutide
1 KG Jul 15, 2026
United States
Semaglutide
10 MG Jul 10, 2026
United States
semaglutide
10 MG Jul 6, 2026
United States
Semaglutide
30 MG Jul 6, 2026 
South Africa
Semaglutide
10 MG Jun 29, 2026
United States
Semaglutide
50 MG Jun 1, 2026
United Kingdom
semaglutide
40 MG May 26, 2026 
Brazil
Semaglutide
5 MG May 8, 2026 
Pakistan
Semaglutide
1 KG Apr 3, 2026
India
Semaglutide
10 MG Apr 1, 2026 Post an enquiry for this product
More from this Seller
-
-
![99% purity Botulinum toxin CAS NO.93384-43-1]( "99% purity Botulinum toxin CAS NO.93384-43-1")
-
99% purity Botulinum toxin CAS NO.93384-43-1
Plating Grade / 99%
$20-23/UNIT FOB
-
-
-
![Tirzepatide Lyophilized powder Vial 5/10/15mg customize 99% Purity Tirzepa Peptide]( "Tirzepatide Lyophilized powder Vial 5/10/15mg customize 99% Purity Tirzepa Peptide")
-
Tirzepatide Lyophilized powder Vial 5/10/15mg customize 99% Purity Tirzepa Peptide
Pharmaceutical Grade / 99%
-
-
-
![IGF-1 98% powder senwayer IGF DES CAS 112603-35-7]( "IGF-1 98% powder senwayer IGF DES CAS 112603-35-7")
-
IGF-1 98% powder senwayer IGF DES CAS 112603-35-7
Plating Grade / 99%
-
